Document Detail


Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report.
MedLine Citation:
PMID:  22123573     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Taking in charge the delivery of pregnant women with inherited major deficiency of factor VII (FVII) is poorly reported in literature. We report here the haemorrhagic prophylaxis of delivery by recombinant activated FVII (rFVIIa) in a 27-year-old women, gravida 1, para 0, with major deficiency FVII by missense mutation (p.Arg337Cys). Her parents, first germen, presented a FVII deficiency. She has four brothers and three sisters, of which only one brother has major FVII deficiency with hemorrhagic diathesis in childhood (hematochezia). At her birth, because of dystocia, a right sterno-cleido-mastoid muscle hematoma and left clavicle fracture occurred. The FVII concentration was 0.08 U/mL. At the age of fifteen, a surgery of appendicitis was performed with substitution by FVII from plasma donors without any haemorrhagic complication. Because of anatomic specificity (bifid uterus and vagina), caesarean was planned. After reviewing of the literature, caesarean was performed at 38th week of gestation with haemorrhagic prophylaxis consisting in administration of rFVIIa (eptacog alfa) at a dose of 20 μg/kg, 30 min before surgery, then every 3 h during 48 h. No haemorrhagic complication occurred. Thrombosis prophylaxis was ensured by enoxaparin (4000 UI a day subcutaneously started 6 h after surgery for 5 days). Clinical examination of the newborn was normal. In future, modalities of taking in charge have to be evaluated by prospective studies involving a sufficiently numerous group of woman with FVII major deficiency, or by retrospective studies with the means of national or European registers.
Authors:
Jean-François Comes; Jean Devignes; Olivier Thiebaugeorges; Marie-Elisabeth Briquel; Thomas Lecompte
Related Documents :
18426353 - Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and lit...
20957053 - Bilateral sporadic aniridia: review of management.
3310963 - Jejunogastric intussusception. a new diagnostic test.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Annales de biologie clinique     Volume:  69     ISSN:  0003-3898     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2984690R     Medline TA:  Ann Biol Clin (Paris)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  713-719     Citation Subset:  -    
Affiliation:
CHU de Nancy, service d'hématologie biologique, Vandoeuvre-lès-Nancy, France.
Vernacular Title:
Utilisation prophylactique du facteur VII activé recombinant dans l'hémorragie de la délivrance par césarienne chez une patiente atteinte de déficit majeur en facteur VII : à propos d'un cas.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Severe lactic acidosis due to metformin: report of 3 cases.
Next Document:  Inappropriately undetectable thyroglobulin after exclusion of interference from thyroglobulin antibo...